Licensed vaccine
Recombivax HB
FDA-licensed vaccine · Merck & Co, Inc · STN BL 101066
Key facts
| Trade name | Recombivax HB |
|---|---|
| Proper name | Hepatitis B Vaccine (Recombinant) |
| Manufacturer | Merck & Co, Inc |
| Submission tracking number (STN) | BL 101066 |
| FDA product areas | Biologics |
| Recent FDA documents | December 21, 2018 Approval Letter - Recombivax HB, Package Insert - Recombivax HB, Supporting Documents older than three years - Recombivax HB |
| FDA page updated | Apr 24, 2019 |
| FDA product page | fda.gov |
At a glance
- 1–9 FDA approval letters
- 1–9 Supporting documents
- 1–9 Product information documents
- Yes Document full text searchable in Orca1
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA-licensed vaccines
The FDA's CBER licenses vaccines for use in the United States. Each product page links the approval letters, package inserts and supporting documents for that vaccine.
Source: U.S. Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER), Vaccines Licensed for Use in the United States · Source date: